ICMT-DT and breast carcinoma: Specifically, Linc00337 was found to upregulate the expression of M2 tumor-associated macrophage markers promoting cell migration and EMT as well as resistance to paclitaxel, a known chemotherapeutic agent used in breast cancer treatment.